NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes

Rosa Lombardi, Lorena Airaghi, Giovanni Targher, Gaetano Serviddio, Gabriele Maffi, Alessandro Mantovani, Claudio Maffeis, Antonio Colecchia, Rosanna Villani, Luca Rinaldi, Emanuela Orsi, Giuseppina Pisano, Luigi Elio Adinolfi, Silvia Fargion, Anna Ludovica Fracanzani

Research output: Contribution to journalArticle

Abstract

We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.

Original languageEnglish
Article number107684
JournalJournal of Diabetes and its Complications
Volume34
Issue number11
DOIs
Publication statusPublished - 2020

Keywords

  • Diabetic neuropathy
  • Microvascular complications
  • NAFLD
  • Non-invasive diagnosis
  • Stroke
  • Type 2 diabetes screening

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes'. Together they form a unique fingerprint.

  • Cite this